tiprankstipranks
RAPT Therapeutics (RAPT)
NASDAQ:RAPT
Holding RAPT?
Track your performance easily

RAPT Therapeutics (RAPT) Financial Statements

313 Followers

RAPT Therapeutics Financial Overview

RAPT Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.78; its P/E ratio is -0.40; RAPT Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -18.43M$ -27.66M$ -32.52M$ -33.92M$ -25.28M
EBITDA$ -18.14M$ -26.38M$ -32.20M$ -33.59M$ -23.57M
Net Income Common Stockholders$ -18.43M$ -27.66M$ -30.52M$ -31.37M$ -25.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 97.91M$ 114.84M$ 141.58M$ 184.78M$ 205.00M
Total Assets$ 108.47M$ 127.18M$ 155.82M$ 199.72M$ 220.76M
Total Debt$ 5.12M$ 5.73M$ 6.32M$ 7.46M$ 8.00M
Net Debt$ -92.78M$ -109.11M$ -135.26M$ -177.31M$ -197.00M
Total Liabilities$ 12.96M$ 17.96M$ 24.98M$ 26.92M$ 21.08M
Stockholders Equity$ 95.51M$ 109.22M$ 130.84M$ 172.80M$ 199.68M
Cash Flow-
Free Cash Flow$ -17.64M$ -28.15M$ -27.19M$ -21.95M$ -29.04M
Operating Cash Flow$ -17.62M$ -28.15M$ -27.08M$ -21.88M$ -28.81M
Investing Cash Flow$ 18.45M$ 19.21M$ 15.89M$ 25.75M$ 32.44M
Financing Cash Flow-$ 701.00K$ 9.04M$ 106.00K$ 767.00K
Currency in USD

RAPT Therapeutics Earnings and Revenue History

RAPT Therapeutics Debt to Assets

RAPT Therapeutics Cash Flow

RAPT Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis